Postmarketing surveillance of enalapril. II: Investigation of the potential role of enalapril in deaths with renal failure
about
Current approaches to renovascular hypertensionPostmarketing surveillance of enalapril. I: Results of prescription-event monitoringEfficacy and dosage of enalapril in congenital and acquired heart disease.Hyperkalemia: a review.Can dual blockade of the renin-angiotensin system reduce progression of kidney disease beyond monotherapy?Perindopril postmarketing surveillance: a 12 month study in 47,351 hypertensive patients.Potential side effects of renin inhibitors--mechanisms based on comparison with other renin-angiotensin blockers.Acute renal failure with ACE inhibition in aortic coarctation.Lipid and other management to improve arterial disease and survival in end stage renal disease.Non-steroidal anti-inflammatory drugs and angiotensin converting enzyme inhibitors: a commonly prescribed combination with variable effects on renal function.Adverse effects of the angiotensin-converting enzyme inhibitors.Coronary flow reserve and the J curve.
P2860
Q24646720-3C6A686C-87FA-4BE6-9A62-ECE5C25DAF8DQ28359865-0598094D-3223-4F40-999D-B679BB9AF56EQ28369543-3DCC9005-3F98-445B-A1DF-53B7A46DB0CBQ34448823-8AE8AB75-D807-4B49-8C54-7B45874BDC0DQ35609741-B555E7C3-1CCA-4969-9F7B-5A846C30C91CQ35803071-82C0AE21-44C6-4870-8043-A1C8F266CB6FQ36565036-15DFF87E-E129-4A9F-BE35-F7AC44572470Q38637455-CD817C3F-8939-4854-969B-AFC24D03E6C1Q39097856-28AA65A6-FC56-447B-A8E4-B085CC0354F5Q40902927-30715F44-430E-4BE5-B0B8-8B9D38EAA5CFQ41084284-A85ED2CA-02A6-4D64-A9AD-F027B7A89852Q42945674-3E264E3C-CEB7-4489-80AB-9F7053724510
P2860
Postmarketing surveillance of enalapril. II: Investigation of the potential role of enalapril in deaths with renal failure
description
1988 nî lūn-bûn
@nan
1988 թուականի Հոկտեմբերին հրատարակուած գիտական յօդուած
@hyw
1988 թվականի հոտեմբերին հրատարակված գիտական հոդված
@hy
1988年の論文
@ja
1988年論文
@yue
1988年論文
@zh-hant
1988年論文
@zh-hk
1988年論文
@zh-mo
1988年論文
@zh-tw
1988年论文
@wuu
name
Postmarketing surveillance of ...... l in deaths with renal failure
@ast
Postmarketing surveillance of ...... l in deaths with renal failure
@en
Postmarketing surveillance of ...... l in deaths with renal failure
@nl
type
label
Postmarketing surveillance of ...... l in deaths with renal failure
@ast
Postmarketing surveillance of ...... l in deaths with renal failure
@en
Postmarketing surveillance of ...... l in deaths with renal failure
@nl
prefLabel
Postmarketing surveillance of ...... l in deaths with renal failure
@ast
Postmarketing surveillance of ...... l in deaths with renal failure
@en
Postmarketing surveillance of ...... l in deaths with renal failure
@nl
P2093
P2860
P356
P1433
P1476
Postmarketing surveillance of ...... l in deaths with renal failure
@en
P2093
C J Speirs
C T Dollery
L V Wilton
N S Rawson
P2860
P356
10.1136/BMJ.297.6652.830
P407
P577
1988-10-01T00:00:00Z